Precision Optics (POCI) closed at $4.32 on October 16, 2026, down 0.7% from the previous close, on volume of 56,953 shares (30-day average 60,973).
Data as of October 16, 2026.
Precision Optics to Participate in the Lytham Partners Fall 2026 Investor Conference
Globe Newswire (Tue, 29-Sep 8:00 AM ET)
Precision Optics Reports Fourth Quarter and Fiscal Year 2026 Financial Results
Globe Newswire (Mon, 28-Sep 4:30 PM ET)
Globe Newswire (Wed, 23-Sep 4:15 PM ET)
Globe Newswire (Thu, 17-Sep 9:00 AM ET)
Globe Newswire (Thu, 10-Sep 9:00 AM ET)
Precision Optics Appoints Peter Thier as Senior Vice President of Sales and Marketing
Globe Newswire (Tue, 18-Aug 9:00 AM ET)
Globe Newswire (Mon, 17-Aug 4:15 PM ET)
Precision Optics Sets New Revenue Records and Improves Margins in Q3 2026: Growth Outlook Raised
Market Chameleon (Thu, 14-May 3:07 AM ET)
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers, which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States. It operates mainly in two key market segments: medical devices and advanced defense/aerospace products.
Precision Optics trades on the NASDAQ stock market under the symbol POCI.
As of October 16, 2026, POCI stock price declined to $4.32 with 56,953 million shares trading.
POCI has a beta of 0.59, meaning it tends to be less sensitive to market movements. POCI has a correlation of 0.03 to the broad based SPY ETF.
POCI has a market cap of $47.40 million. This is considered a Sub-Micro Cap stock.
Last quarter Precision Optics reported $9 million in Revenue and -$.01 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.05.
In the last 3 years, POCI traded as high as $6.90 and as low as $3.47.
The top ETF exchange traded funds that POCI belongs to (by Net Assets): VTI, VXF, IWC.
POCI has underperformed the market in the last year with a price return of +3.8% while the SPY ETF gained +16.7%. POCI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -2.9% and -3.1%, respectively, while the SPY returned +1.9% and -0.8%, respectively.
POCI support price is $4.18 and resistance is $4.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that POCI shares will trade within this expected range on the day.